Simplicity Solutions’s BeOne Medicines Ltd ONC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$667K Sell
3,700
-128
-3% -$23.2K 0.02% 566
2023
Q3
$689K Buy
3,828
+59
+2% +$11.7K 0.02% 518
2023
Q2
$672K Sell
3,769
-855
-18% -$197K 0.02% 581
2023
Q1
$997K Buy
4,624
+1,097
+31% +$263K 0.03% 487
2022
Q4
$776K Buy
3,527
+202
+6% +$37K 0.11% 246
2022
Q3
$448K Buy
3,325
+56
+2% +$9.62K 0.07% 343
2022
Q2
$529K Buy
+3,269
New +$511K 0.07% 291
2022
Q1
Sell
-2,452
Closed -$664K 651
2021
Q4
$664K Buy
2,452
+1,639
+202% +$553K 0.07% 320
2021
Q3
$295K Buy
813
+59
+8% +$19.3K 0.05% 447
2021
Q2
$259K Buy
754
+123
+19% +$40.7K 0.05% 429
2021
Q1
$220K Buy
+631
New +$209K 0.05% 448

Other funds holding ONC

Simplicity Solutions's ONC Position: Q4 2023 in Review

Simplicity Solutions reduced its BeOne Medicines Ltd (ONC) stake by 3.3% in Q4 2023, selling an estimated $23.2K and leaving 3,700 shares worth $667K. The position accounts for 0.02% of the portfolio, ranked #566.

Simplicity Solutions first reported a position in ONC in Q1 2021 and has held it in 11 quarters since. The position peaked at $997K in Q1 2023. 203 funds tracked by Wall St. Rank hold ONC as of Q4 2023.

  • Simplicity Solutions held 3,700 shares of BeOne Medicines Ltd worth $667K as of Q4 2023.
  • Simplicity Solutions sold 128 BeOne Medicines Ltd shares in Q4 2023, an estimated $23.2K.
  • BeOne Medicines Ltd made up 0.02% of Simplicity Solutions's portfolio in Q4 2023, its #566 holding.
  • Simplicity Solutions first reported a position in BeOne Medicines Ltd in Q1 2021 and has held it in 11 quarters since.
  • Simplicity Solutions's BeOne Medicines Ltd position peaked at $997K in Q1 2023.
  • 203 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q4 2023.

Based on Simplicity Solutions's 13F filing for Q4 2023, filed 29 Jan 2024.